In LPS-treated adult male mice, minocycline and the IDO antagonist 1-methyltryptophan rescued the development of MDD-like behavior, independently of brain serotonin turnover (O’Connor et al., 2009). The gene discussed is IDO1; the disease is major depressive disorder.